Patient experience of CAR T-cell therapy
February 14, 2020
“I’m afraid around 50% of your bone marrow is made up of blast cells”. That’s not exactly the news you want after already enduring UKALL14 induction, two rounds of FLAG-Ida and a non-related donor bone marrow transplant to treat your acute lymphoblastic leukaemia.
Know More
There is a strong woman, her name is Zainab. She’s 26 years old, and she comes from Pakistan. Why I say she’s strong? Here is her story.
Aug 02, 2019
A wonderful wedding is every woman’s dream, and she was going to marry the man she loves. Everything was perfect, and everyone was busy to prepare the wedding. And suddenly things changed
Know More
Emily has been living a healthy life for more than 7 years after received CAR-T Treatment
February 02, 2019
Emily was the first child to receive CAR-T therapy. She has been living a healthy life for more than 7 years since she got the CAR-T treatment. She is also considered as one of the representatives of such an unprecedented therapy.
Know More
Junaid, 19, was diagnosed with "acute B lymphocytic leukemia
Aug 02, 2019
Junaid, 19, was diagnosed with "acute B lymphocytic leukemia" after multiple tests at a Pakistani hospital for recurrent fever
Know More
Maisha, a 4.5 years old girl comes from Pakistan.
Aug 02, 2019
Maisha, a 4.5 years old girl comes from Pakistan. In September 2014, has the first symptoms "fever and cough"
Know More
29-years-old man comes from Hong Kong
Aug 02, 2019
The Excellent CAR-T Clinical Trial Saves Hong Kong ALL Patient Shawn, 29-years-old man comes from Hong Kong
Know More
Bone Marrow Transplantation Make Acute Myeloid Leukemia Kid Got into Complete Remission
Aug 02, 2019
>Bone Marrow Transplantation Make Acute Myeloid Leukemia Kid Got into
Know More
Cart Cell Therapy Saves Children with Leukemia in China
Aug 02, 2019
>China Car-t Save Leukemia Children，Cart Cell Therapy Saves Children with Leukemia in China
Know More
Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient
Aug 02, 2019
>Chimeric antigen receptor (CAR) gene therapy is a breakthrough technology in treating refractory hematologic malignancies
Know More
CD19-CAR-T cell immunotherapy for refractory/relapse B-ALL patients
Aug 02, 2019
>CD19-CAR-T cell immunotherapy for refractory/relapse B-ALL patients could result in high CR /incomplete count recovery (CRi) rate including extramedullary leukemia.
Know More